AzTrials
AzTrials

RelaxationRELAXPREOPNCT07557550

Comparison of Two Relaxation Strategies Between Glasses, Virtual Reality Headset, and Without Relaxation Tool, in the Anxiety Preoperative of Orthopedic Adult Patients

A study testing HypnoVR, PSIO and no relaxation tool in people with Relaxation and Virtual Reality, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In adults, the prevalence of preoperative anxiety related to surgery or anesthesia ranges from 60 to 80%, and context plays an important role. Patients with significant preoperative anxiety experience reduced sleep quality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Relaxation, Virtual Reality, Anxiety Preoperative
What is being tested?
HypnoVR, PSIO and no relaxation tool
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
632 participants
Where
1 siteFrance
Study dates
1 Apr 2026to Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient treated at the UAC D0
  • Orthopedic patient (arthroplasty mainly)
  • Anesthesic procedure with general anesthesia
  • Patient >18 years old without cognitive impairment in the investigator's judgment
  • Patient who has signed a free and informed consent
  • Patient affiliated to a social security scheme

Who cannot join

  • Patient with deafness that does not allow him to perceive and understand sounds
  • Patient with a visual impairment who does not allow him to watch and understand a video
  • Patient who does not master the French language (spoken, written and read)
  • Patient with a history of epilepsy
  • Patient with a history of migraine/headache when using a virtual reality headset
  • Patients with a history of dizziness triggered by images (film, video game...)
Show all 10Show fewer
  • Patient with untreated dry eye disease
  • Patient with psychiatric diseases and disorders not compatible with the study in the investigator's judgment
  • Patient who is pregnant, parturient, or breastfeeding.
  • Patient under guardianship or curatorship, under judicial protection or deprived of public law

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

François JOACHIM, MD contact

33+322088671

Joachim.francois@chu-amiens.fr

France1 site, 1 recruiting
  • Amiens University Hospital

    Amiens, Picardie, 80054

    François Joachim, MD, 33+322088671, Joachim.francois@chu-amiens.fr

    Sandrine SORIOT-THOMAS, MD

    Recruiting

Other trials in France

About this study

In adults, the prevalence of preoperative anxiety related to surgery or anesthesia ranges from 60 to 80%, and context plays an important role. Patients with significant preoperative anxiety experience reduced sleep quality. In addition, high preoperative anxiety is linked to more severe postoperative pain and an increased need for painkillers. In addition, it is a source of dysfunction in care. Currently, there are no recommendations regarding the prevention of preoperative anxiety. New approaches have emerged that show some benefit: music, binaural auditory stimulation and hypnosis. In the UAC J0 unit of the Amiens-Picardie University Hospital, the caregivers offer the PSiO glasses, a tool combining three techniques: light therapy, relaxation and chromotherapy. This system has obtained CE and FCC markings and seems to be more or less effective on patients admitted to the CH . A pilot study evaluating the effects of virtual reality hypnosis on patients' preoperative anxiety has shown that this technology represents a non-invasive way to reduce preoperative stress levels without side effects and without the need for additional medical or paramedical staff. This study aims to improve the patient's well-being before their operation. Depending on the randomization, he will benefit from a relaxation session with the Psio glasses or a virtual reality hypnosis session with the Hypno VR headset. Follow-up of patients will be carried out on the basis of variation in an anxiety scale, physiological criteria, the amount of anesthetic products used, the time spent in the recovery room, and the evaluation of pain.

Being tested
HypnoVR, PSIO, no relaxation tool
Keywords
relaxation, virtual reality, anxiety preoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HypnoVRDevice

    The patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.

  • PSIODevice

    the patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.

  • no relaxation toolDevice

    Group without relaxation tool: the patient will wait 20-minute, without benefit of sendorial tools.

Study groups in NCT07557550
Study groupRoleWhat they receive
HypnoVR groupExperimentalThe patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.
Receives: Device: HypnoVR
PSIO GroupExperimentalthe patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.
Receives: Device: PSIO
Group without relaxation toolSham comparatorthe patient will wait 20-minute, without benefit of sendorial tools.
Receives: Device: no relaxation tool

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation in the score on the APAIS anxiety scale

    Variation in the score on the APAIS scale, 6-item scale rated from 1 to 5 The anxiety score sums items 1, 2, 4 and 5 (>11 = anxious subjects) The information desire score sums items 3 and 6 (2 to 4 = refusal of information, 5 to 7 = average desire for information, >7 = eager desire for information)

    Measured: 1 hour

Secondary outcomes (7)
  1. Heart rate variation

    Heart rate variation measured by a pulse oximeter

    Measured: 1 hour

  2. Variation in respiratory rate

    Variation in respiratory rate measured over 1 minute with a stopwatch

    Measured: over 1 minute

  3. Blood pressure variation

    Blood pressure variation measured with a blood pressure monitor

    Measured: 1 hour

  4. Variation in oxygen saturation

    Variation in oxygen saturation measured with a pulse oximeter

    Measured: 1 hour

  5. Quantity of product used

    Quantity of product used as recorded in the electronic patient record

    Measured: 1 hour

  6. Time spent in the recovery room

    Time spent in the recovery room recorded in the computerized patient file

    Measured: 1 hour

  7. Level of pain

    Level of pain measured by a VAS

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2026
  2. Study start1 Apr 2026
  3. Primary completionApr 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
632 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07557550
Sponsor's protocol ID
PI2025_843_0184
Acronym
RELAXPREOP
Status last verified
Apr 2026
First submitted
23 Apr 2026
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing HypnoVR, PSIO and no relaxation tool in people with Relaxation and Virtual Reality, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact François JOACHIM, MD (33+322088671, Joachim.francois@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation in the score on the APAIS anxiety scale (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in